Astellas and Medivation sign development agreement

Oct 29, 2009 24 related
 

Oct 29, 2009 (Datamonitor via COMTEX) -- Astellas Pharma, a Japanese pharmaceutical company, and Medivation, a US-based biopharmaceutical company, have entered into a global agreement to develop and commercialize MDV3100,... [read full story]                    

powered by
Add Comment
There are also 24 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies